Burleson Andrew, Guler Nil, Banos Andrew, Syed Daneyal, Wanderling Christopher, Hoppensteadt Debra, Rees Harold, Fareed Jawed, Hopkinson William
Department of Orthopaedic Surgery and Rehabilitation, Loyola University Medical Center, Maywood, IL, USA.
Department of Pathology and Pharmacology, Loyola University Medical Center, Maywood, IL, USA
Clin Appl Thromb Hemost. 2016 Apr;22(3):274-9. doi: 10.1177/1076029615611251. Epub 2015 Oct 11.
Total joint arthroplasty (TJA) patients are mostly of advanced age and with comorbidities such as increased body mass index (BMI) and impaired glucose tolerance. These factors and type of surgery may affect the fibrinolytic system.
To investigate the effect of age, sex, BMI, type of surgery, and tranexamic acid (TXA) treatment on the fibrinolytic system in TJA patients.
Ninety-nine patients undergoing TJA (32 total hip arthroplasty [THA] and 67 total knee arthroplasty [TKA]) were included in this study. Blood samples were drawn at preoperative clinic appointments and on postoperative day 1. Antigenic levels of d-dimer, plasminogen activator inhibitor 1 (PAI-1), and tissue plasminogen activator (tPA) were measured using a commercially available enzyme-linked immunosorbent assay kit. Antiplasmin activity was measured using functional method. Age, gender, hemoglobin (Hb) levels, and BMI were collected from the records.
Preoperative d-dimer and tPA levels were positively correlated with age, whereas preoperative antiplasmin was negatively correlated with age. Body mass index was only associated with preoperative tPA levels. There was no significant difference in postoperative levels of d-dimer, PAI-1, tPA, or antiplasmin between patients treated with TXA or without TXA. Percentage change in d-dimer and tPA showed significantly lower values in patients treated with TXA compared to the nontreated group. Type of surgery did not affect the fibrinolytic markers.
These results confirm that advanced age and elevated BMI positively contribute to fibrinolytic dysregulation in TJA patients, whereas TXA seems to decrease the fibrinolytic activity.
全关节置换术(TJA)患者大多为高龄且伴有合并症,如体重指数(BMI)增加和糖耐量受损。这些因素以及手术类型可能会影响纤溶系统。
研究年龄、性别、BMI、手术类型和氨甲环酸(TXA)治疗对TJA患者纤溶系统的影响。
本研究纳入了99例行TJA的患者(32例行全髋关节置换术[THA],67例行全膝关节置换术[TKA])。在术前门诊预约时和术后第1天采集血样。使用市售酶联免疫吸附测定试剂盒测量D-二聚体、纤溶酶原激活物抑制剂1(PAI-1)和组织纤溶酶原激活物(tPA)的抗原水平。使用功能方法测量抗纤溶活性。从记录中收集年龄、性别、血红蛋白(Hb)水平和BMI。
术前D-二聚体和tPA水平与年龄呈正相关,而术前抗纤溶与年龄呈负相关。体重指数仅与术前tPA水平相关。接受TXA治疗和未接受TXA治疗的患者术后D-二聚体、PAI-1、tPA或抗纤溶水平无显著差异。与未治疗组相比,接受TXA治疗的患者D-二聚体和tPA的百分比变化值显著更低。手术类型不影响纤溶标志物。
这些结果证实,高龄和BMI升高对TJA患者纤溶失调有积极影响,而TXA似乎会降低纤溶活性。